semaglutide mce Antibody Semaglutide promotes the proliferation and

Wedelolactone from Eclipta alba inhibits lipopolysaccharide-enhanced cell proliferation of human renal mesangial cells via NF-B signaling pathway

Food and Drug Administration are facilitating the quick commercialization of next-generation obesity drugs through favorable regulatory frameworks and expedited approval procedures

Patients with certain FTO and MC4R variants, for example, often show stronger initial appetite suppression

However, this CD47-HuR reprogramming exosome can achieve the long-term integration and stable expression of therapeutic genes

Patients must be willing to make long-term changes to their eating and activity habits to achieve the best results

A randomized study and open-label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes